PRESS RELEASE published on 07/06/2026 at 19:14, 3 months 10 days ago Informations privilégiées / Autres communiqués Bilan semestriel du contrat de liquidité portant sur les actions de la société ABIONYX Pharma, confié à la Société TP ICAP (Europe) SA, avec détails des transactions et soldes en espèces Contrat Bilan Semestriel Transactions Liquidité ABIONYX Pharma
BRIEF published on 06/30/2026 at 19:13, 3 months 16 days ago ABIONYX Pharma obtient des fonds pour faire progresser le traitement de la septicémie ABIONYX Pharma CER-001 Traitement De La Septicémie Plateforme ApoA-I Financement Financier
BRIEF published on 06/30/2026 at 19:13, 3 months 16 days ago ABIONYX Pharma Secures Funding to Advance Sepsis Treatment ABIONYX Pharma CER-001 Financial Funding Sepsis Treatment ApoA-I Platform
BRIEF published on 06/30/2026 at 19:13, 3 months 16 days ago ABIONYX Pharma en pleine expansion après son Assemblée Générale ABIONYX Pharma Sepsis CER-001 Assemblée Générale 2026 Plateforme ApoA-I
BRIEF published on 06/30/2026 at 19:13, 3 months 16 days ago ABIONYX Pharma is expanding rapidly following its General Meeting ABIONYX Pharma Sepsis CER-001 General Assembly 2026 ApoA-I Platform
PRESS RELEASE published on 06/30/2026 at 19:08, 3 months 16 days ago Informations privilégiées / Autres communiqués ABIONYX Pharma change d'échelle suite à la sécurisation des moyens de son ambition et ouvre un nouveau cycle de création de valeur dans les inflammations sévères et le sepsis ABIONYX Pharma Sepsis Création De Valeur Innovantes Inflammations Sévères
PRESS RELEASE published on 06/30/2026 at 19:08, 3 months 16 days ago Inside Information / Other news releases ABIONYX Pharma scales up operations after securing resources, focusing on value creation in inflammation and sepsis treatment. Updates on pivotal clinical trial, financial visibility, and scientific platform development Financial Resources Clinical Trial ABIONYX Pharma Sepsis Inflammation Treatment
BRIEF published on 06/18/2026 at 07:35, 3 months 29 days ago ABIONYX Pharma finalise avec succès un financement de 33 millions d'euros. Augmentation De Capital ABIONYX Pharma Fenja Capital Financement Par Obligations Recherche Sur La Septicémie
BRIEF published on 06/18/2026 at 07:35, 3 months 29 days ago ABIONYX Pharma Completes Successful EUR 33 Million Financing Capital Increase Bond Financing ABIONYX Pharma Fenja Capital Sepsis Research
BRIEF published on 06/18/2026 at 07:35, 3 months 29 days ago ABIONYX Pharma successfully completes its capital increase Capital Increase Clinical Trial Bond Financing Sepsis Fenja Capital
Published on 10/17/2026 at 03:20, 9 hours 21 minutes ago Battery X Metals Highlights Participation at X Takeover 2026, an Electric Vehicle and Emerging Technology Event Held at Tesla's Gigafactory Texas, Providing Exposure to Industry Perspectives and Technology Developments
Published on 10/17/2026 at 03:15, 9 hours 26 minutes ago Vanta Closes Second Tranche of Private Placement Financing and Welcomes Launch of First U.S.-Listed Peptide ETF, Highlighting Growing Recognition of Peptide Industry
Published on 10/16/2026 at 23:35, 13 hours 6 minutes ago Initial Closing of US$3.4 Million Private Placement
Published on 10/16/2026 at 23:30, 13 hours 11 minutes ago NiobiumX Mining Inc. Announces Retraction of Recent Marketing Materials
Published on 10/16/2026 at 23:00, 13 hours 41 minutes ago Grid Announces Adoption of Advance Notice By-Law and Provides Shareholder Meeting Update
Published on 10/16/2026 at 20:08, 16 hours 32 minutes ago EQS-Adhoc: Rath AG // Rath Group reaches agreement with its key financial creditors on the terms of a transformation agreement and launches a transformation programme
Published on 10/16/2026 at 19:20, 17 hours 21 minutes ago Arity to Acquire INRIX, Advancing a Connected Vision for the Future of Transportation
Published on 10/16/2026 at 19:05, 17 hours 36 minutes ago Paris Court Ruling on Discontinued Feature Will Have Minimal Impact on Angelalign Customers
Published on 10/16/2026 at 18:18, 18 hours 23 minutes ago Issue Price of Placing and WRAP Retail Offer
Published on 10/16/2026 at 18:13, 18 hours 27 minutes ago EQS-Adhoc: DHL AG: DHL AG raises full-year 2026 earnings guidance
Published on 10/16/2026 at 19:54, 16 hours 47 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 30 septembre 2026
Published on 10/16/2026 at 18:48, 17 hours 53 minutes ago Disclosure of transactions in own shares from October 12 to October 16, 2026
Published on 10/16/2026 at 18:48, 17 hours 53 minutes ago Déclaration hebdomadaire d'opérations effectuées du 12 au 16 octobre 2026
Published on 10/16/2026 at 18:00, 18 hours 41 minutes ago KLARSEN : Compte rendu AGO et AGE du 8 octobre 2026
